Shionogi Announces Patent Victory Over Challenge Of Eight U.S. Generics
This article was originally published in PharmAsia News
Executive Summary
Shionogi said a U.S. lawsuit has been settled in its favor, defeating a patent challenge by eight U.S. generics makers to the Japan-based company's anti-cholesterol drug Crestor.